Austrian COVID-19 patients with severe lung dysfunction for the first time have a treatment option within a compassionate use program for Apeptico’s solnatide.
Following the completion of Danaher’s €19.5bn take-over of GE Healthcare Life Sciences, GE’s CDMO arm is renamed Cytiva.
Austrian APEPTICO has got Horizon 2020 money for accelerated development and clinical use of Solnatide for the treatment of COVID-19 patients
The European Medicines Agency EMA has backed eight medicines for approval at its virtual March 2020 meeting.
Scandinavian researchers have created a unified, open-source model providing a genome-wide portrait of human disease metabolism.
Paris-based Novacyt SA has signed a global distribution agreement with Bruker Ltd for its COVID-19 diagnostic test.
AC Immune SA has received a milestone payment of CHF10m from Eli Lilly and Company.
Scientists have discussed a link between Covid-19 and sepsis at a virtual symposium at Charité Berlin that might help reduce the burden of end-stage disease.
Evonik Industries has established a new animal-free and fermentation-based industrial-scale recombinant collagen production platform.